These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 24883442)
1. PROGNOSIS looking good for a possible serum test for preeclampsia. Dowdall M Future Cardiol; 2014 Mar; 10(2):164-5. PubMed ID: 24883442 [No Abstract] [Full Text] [Related]
2. Circulating angiogenic factors and preeclampsia. Tsatsaris V; Goffin F; Foidart JM N Engl J Med; 2004 May; 350(19):2003-4; author reply 2003-4. PubMed ID: 15128904 [No Abstract] [Full Text] [Related]
4. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Lapaire O; Shennan A; Stepan H Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):122-9. PubMed ID: 20457483 [TBL] [Abstract][Full Text] [Related]
5. Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Stepan H; Herraiz I; Schlembach D; Verlohren S; Brennecke S; Chantraine F; Klein E; Lapaire O; Llurba E; Ramoni A; Vatish M; Wertaschnigg D; Galindo A Ultrasound Obstet Gynecol; 2015 Mar; 45(3):241-6. PubMed ID: 25736847 [No Abstract] [Full Text] [Related]
6. Preeclampsia -- searching for the cause. Solomon CG; Seely EW N Engl J Med; 2004 Feb; 350(7):641-2. PubMed ID: 14764924 [No Abstract] [Full Text] [Related]
7. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977 [TBL] [Abstract][Full Text] [Related]
9. Angiogenic factors for the prediction of preeclampsia in high-risk women. Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405 [TBL] [Abstract][Full Text] [Related]
10. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia]. Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913 [TBL] [Abstract][Full Text] [Related]
17. Case records of the Massachusetts General Hospital. Case 38-2005. A 29-year-old pregnant woman with the nephrotic syndrome and hypertension. Williams WW; Ecker JL; Thadhani RI; Rahemtullah A N Engl J Med; 2005 Dec; 353(24):2590-600. PubMed ID: 16354896 [No Abstract] [Full Text] [Related]
18. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia. Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831 [TBL] [Abstract][Full Text] [Related]
19. Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation. Lai J; Garcia-Tizon Larroca S; Peeva G; Poon LC; Wright D; Nicolaides KH Fetal Diagn Ther; 2014; 35(4):240-8. PubMed ID: 24853452 [TBL] [Abstract][Full Text] [Related]
20. Early prediction of preeclampsia in high-risk women. Shaker OG; Shehata H J Womens Health (Larchmt); 2011 Apr; 20(4):539-44. PubMed ID: 21413896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]